MedTrace Logo

Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women.

NCT02775448 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2019-02-28

No results posted yet for this study

Summary

Metabolic disorders including hypercholesterolemia and hypertriglyceridemia are present in climacteric women. Carduus marianus is a homeopathic medicine that traditionally has been used for hepatic diseases. It has been used for reducing hypercholesterolemia and hypertriglyceridemia also. The aim of this study is to investigate the most effective dose of Carduus marianus in centesimal scale (6cH, 12cH, 30cH, placebo) plus diet and exercise for reducing hypertriglyceridemia and/or hypercholesterolemia in climacteric women.

Conditions

Interventions

DRUG

Carduus marianus 6cH

DRUG

Carduus marianus 12cH

DRUG

Carduus marianus 30cH

DRUG

Placebo

BEHAVIORAL

Exercise

aerobic exercise, 30 minutes, daily

OTHER

Diet

1600 calories

Sponsors & Collaborators

  • Laboratorio Similia, México

    collaborator UNKNOWN

  • Hospital Nacional Homeopático, Mexico

    lead OTHER

Principal Investigators

  • Emma del Carmen Macias-Cortes, PhD · Hospital Nacional Homeopático

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-08-31
Completion
2017-09-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02775448 on ClinicalTrials.gov